Management of Sinistral Portal Hypertension after Pancreaticoduodenectomy

Dig Dis. 2024;42(2):178-185. doi: 10.1159/000535774. Epub 2024 Jan 5.

Abstract

Background: Sinistral, or left-sided, portal hypertension (SPH) is a rare cause of upper gastrointestinal (GI) hemorrhage resulting from obstruction of the splenic vein. Venous drainage from the spleen via collaterals can result in venous hemorrhage into both the retroperitoneal and intra-abdominal spaces due to increased venous blood pressure in peripancreatic and gastroduodenal vasculature. SPH can occur secondary to pancreatitis with thrombosis of the splenic vein. Another possible cause is the surgical ligation of the splenic vein as part of pancreaticoduodenectomy (PD). Although splenectomy has been traditionally considered as the treatment of choice to relieve venous hypertension, individual concepts for each patient have to be developed. Considering the venous collateral drainage pathways, a comprehensive approach involving surgical, endoscopic, and interventional radiology interventions may be necessary to address the underlying cause of variceal bleeding. Among these approaches, splenic artery embolization (SAE) has demonstrated efficacy in mitigating the adverse effects associated with elevated venous outflow pressure.

Summary: This review summarizes key imaging findings in SPH patients after PD and highlights the potential of minimally invasive embolization for curative treatment of variceal hemorrhage.

Key messages: (i) SPH is a potential consequence after major pancreas surgery. (ii) Collateral flow can lead to life-threatening abdominal bleeding. (iii) Depending on the origin and localization of the bleeding, a dedicated management is required, frequently involving interventional radiology techniques.

Keywords: Pancreaticoduodenectomy; Sinistral portal hypertension; Splenic artery embolization.

Publication types

  • Review

MeSH terms

  • Esophageal and Gastric Varices* / complications
  • Gastrointestinal Hemorrhage / etiology
  • Humans
  • Hypertension, Portal* / etiology
  • Hypertension, Portal* / therapy
  • Pancreaticoduodenectomy / adverse effects
  • Sinistral Portal Hypertension*

Grants and funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.